Doubling of Decipher Biopsy Genomic Score Is Related to Disease Reclassification on Subsequent Surveillance Biopsy but Not Adverse Features on Radical Prostatectomy

Table 1

Biomarker measures during active surveillance.

	First biopsy (7/2016)	Second biopsy (8/2017)	Third biopsy (12/2018)
PSA (ng/mL)	6.3	5.7	9.1
% free PSA	—	—	13.2
PHI	—	—	47.3
Biopsy	x	x	x
Decipher score	0.15	0.36	—
Prostate volume (mL)	79	91	90
PSA density (ng/mL/mL)	0.08	0.06	0.10